Clinical Trials in Los Angeles

Showing 9721-9740 of 14,465 trials

Safety Evaluation of 3K3A-APC in Ischemic Stroke

NCT02222714

The purpose of this study was to evaluate the safety, pharmacokinetics (PK) and preliminary efficacy of multiple ascending intravenous doses of 3K3A-APC, a Recombinant Variant of Human activated protein C (APC), in in the treatment of acute ischemic stroke following treatment with recombinant tissue plasminogen activator (tPA), mechanical thrombectomy or both.

Ischemic Stroke

ZZ Biotech, LLC110 participantsStarted Oct 2014

Los Angeles, California, United States • Chicago, Illinois, United States • Kansas City, Kansas, United States +12 more locations

COMPLETEDNA< 1 mile

Preparing to Run Effective Prevention

NCT02135991

Young people can engage in a variety of negative behaviors-such as drug use, underage drinking, and premarital sex-that exact a high toll on local communities. These activities are often the target of community-based prevention efforts. Getting To Outcomes (GTO) is an approach that includes a toolkit, technical assistance, and training, organized around a 10-step process, that helps communities plan, implement, and evaluate the impact of their programs that attempt to prevent these negative behaviors. This study will examine the degree to which Getting To Outcomes helps Boys and Girls Clubs implement an evidence based drug prevention program.

Implementation of Evidence Based Programs

RAND990 participantsStarted Sep 2013

Buena Park, California, United States • Burbank, California, United States • Carson, California, United States +12 more locations

Safety Evaluation of 3K3A-APC in Ischemic Stroke

Preparing to Run Effective Prevention

Find Trials by Condition in Los Angeles

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Harnessing mHealth and Social Support to Improve Diabetes Related Health Behavior for Inner-city Patients

A Study of Enzastaurin in Participants With Follicular Lymphoma

Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings

Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment

A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration

First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects

Safety and Efficacy of Cariprazine in Schizophrenia

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Global Non-interventional Heart Failure Disease Registry

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.